Birth of a Healthy Baby 9 Years after a Surgically Successful Deceased Donor Uterus Transplant

ArticleAçık Erişim

Özet

Objective:To describe surgical procedures, previous failed pregnancies, methods for overcoming pregnancy failure and, most importantly, birth of a healthy infant, in a uterus transplantation from a deceased donor.Background:Majority of uterus transplants have involved live donors, but several advantages make deceased donor transplantation a practicable option, principally by eliminating surgical risks to the live donor.Methods:Uterus transplantation from a deceased donor was performed in September 2011 in Turkey. After 5 miscarriages, perfusion computed tomography revealed an obstructed blood-outflow. To overcome this blood flow obstruction, a saphenous vein graft was anastomosed between utero-ovarian and left ovarian vein with laparotomy. Follow-up computed tomography confirmed resolution of venous congestion and a decrease in uterine volume.Results:Following vascular augmentation surgery, fetal cardiac activity were observed 28 days after the first embryo transfer attempt. Preterm premature rupture of the membranes was diagnosed at 19 weeks' gestation. Cesarean section was planned at 28 weeks' gestation due to intrauterine growth restriction and suspected preeclampsia. A healthy 760 g male baby was delivered. The baby was discharged from the neonatal intensive care unit 79 days after delivery in good condition weighing 2475 g.Conclusions:Deceased donor uterus transplantation is a reasonable approach for treating uterine factor-related infertility. In case of recurrent miscarriages, regional vascular augmentation by arterial or venous supercharging may be required to overcome regional misperfused regions determined by imaging studies. © 2022 Lippincott Williams and Wilkins. All rights reserved.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12569Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorOzkan, Omer
dc.contributor.authorOzkan, Ozlenen
dc.contributor.authorDogan, Nasuh Utku
dc.contributor.authorBahceci, Mustafa
dc.contributor.authorMendilcioglu, Inane
dc.contributor.authorBoynukalin, Kubra
dc.contributor.authorOngun, Hakan
dc.contributor.authorKantarci, Abdul Mecit
dc.contributor.authorYaprak, Muhittin
dc.contributor.authorCengiz, Melike
dc.contributor.authorHadimioglu, Necmiye
dc.contributor.authorKafadar, Yusuf Taner
dc.contributor.authorCelik, Kiymet
dc.date.accessioned2026-10-18T20:27:27.373038208Z
dc.date.available2026-10-18T20:27:27.373038208Z
dc.date.issued2022
dc.description.abstractObjective:To describe surgical procedures, previous failed pregnancies, methods for overcoming pregnancy failure and, most importantly, birth of a healthy infant, in a uterus transplantation from a deceased donor.Background:Majority of uterus transplants have involved live donors, but several advantages make deceased donor transplantation a practicable option, principally by eliminating surgical risks to the live donor.Methods:Uterus transplantation from a deceased donor was performed in September 2011 in Turkey. After 5 miscarriages, perfusion computed tomography revealed an obstructed blood-outflow. To overcome this blood flow obstruction, a saphenous vein graft was anastomosed between utero-ovarian and left ovarian vein with laparotomy. Follow-up computed tomography confirmed resolution of venous congestion and a decrease in uterine volume.Results:Following vascular augmentation surgery, fetal cardiac activity were observed 28 days after the first embryo transfer attempt. Preterm premature rupture of the membranes was diagnosed at 19 weeks' gestation. Cesarean section was planned at 28 weeks' gestation due to intrauterine growth restriction and suspected preeclampsia. A healthy 760 g male baby was delivered. The baby was discharged from the neonatal intensive care unit 79 days after delivery in good condition weighing 2475 g.Conclusions:Deceased donor uterus transplantation is a reasonable approach for treating uterine factor-related infertility. In case of recurrent miscarriages, regional vascular augmentation by arterial or venous supercharging may be required to overcome regional misperfused regions determined by imaging studies. © 2022 Lippincott Williams and Wilkins. All rights reserved.
dc.description.sponsorshipWe would like to thank Turkish Ministry of Health and Akdeniz University Scientific Research Council for their support.
dc.identifier.doi10.1097/sla.0000000000005346
dc.identifier.eissn1528-1140
dc.identifier.endpage832
dc.identifier.issn0003-4932
dc.identifier.issue5
dc.identifier.pmid35129480
dc.identifier.scopus2-s2.0-85129999540
dc.identifier.startpage825
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/12569
dc.identifier.volume275
dc.identifier.wosWOS:000793253900016
dc.language.isoen
dc.publisherLippincott Williams and Wilkins
dc.relation.ispartofAnnals of Surgery
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectdeceased donor
dc.subjectlive birth
dc.subjectrepeated miscarriages
dc.subjectuterus transplantation
dc.subjectvascular revision
dc.subjectCesarean Section
dc.subjectFemale
dc.subjectHumans
dc.subjectInfant, Newborn
dc.subjectLiving Donors
dc.subjectMale
dc.subjectPregnancy
dc.subjectUterus
dc.subjectazathioprine
dc.subjectbetamethasone
dc.subjectC reactive protein
dc.subjectceftriaxone
dc.subjectchorionic gonadotropin
dc.subjectenoxaparin
dc.subjectestradiol
dc.subjectfollitropin
dc.subjectgentamicin
dc.subjectHLA A antigen
dc.subjectHLA antigen
dc.subjectHLA B antigen
dc.subjectHLA DRB1 antigen
dc.subjectmetronidazole
dc.subjectMuellerian inhibiting factor
dc.subjectpenicillin derivative
dc.subjectprednisolone
dc.titleBirth of a Healthy Baby 9 Years after a Surgically Successful Deceased Donor Uterus Transplant
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus39
rdl.citation.wos36
rdl.departmentErzincan Binali Yildirim University Faculty of Radiology, Erzincan, Turkey.
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)